A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
Carline van den Dool , Eelko Hak, Marc J.M. Bonten1, and Jacco Wallinga1
Author affiliations: University Medical Center, Utrecht, the Netherlands (C. van den Dool, E. Hak, M.J.M. Bonten, J. Wallinga); University Medical Center, Groningen, the Netherlands (E. Hak); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (J. Wallinga)
Figure 2. Effects of prophylaxis with oseltamivir on influenza virus infection and disease rates among nursing home patients. The effects of both postexposure and continuous prophylaxis strategies are shown for different proportions of resistant virus strains in the community and compared with a control setting without prophylaxis and resistance. Panels A and C, postexposure prophylaxis given to all patients; panel B and D, continuous prophylaxis for 8 weeks. BL, baseline.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.